(2S,3S,4S,5S,6R)-2-[[(2R,3S,4S,5S)-4,6-Dihydroxy-3,5-bis[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Term ID

CHEBI:153692

Synonyms

alpha-D-manno-hexopyranosyl-(1->2)-[alpha-D-manno-hexopyranosyl-(1->4)][alpha-D-manno-hexopyranosyl-(1->6)]-D-manno-hexopyranose
Man(a1-2)[Man(a1-4)][Man(a1-6)]Man
WURCS=2.0/2,4,3/[a1122h-1x_1-5][a1122h-1a_1-5]/1-2-2-2/a2-b1_a4-c1_a6-d1

Definition

References

GlyGen:G79989ST
GlyTouCan:G79989ST

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2S,3S,4S,5S,6R)-2-[[(2R,3S,4S,5S)-4,6-Dihydroxy-3,5-bis[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype where environments contain (2S,3S,4S,5S,6R)-2-[[(2R,3S,4S,5S)-4,6-Dihydroxy-3,5-bis[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype modified by environments containing (2S,3S,4S,5S,6R)-2-[[(2R,3S,4S,5S)-4,6-Dihydroxy-3,5-bis[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype affecting (2S,3S,4S,5S,6R)-2-[[(2R,3S,4S,5S)-4,6-Dihydroxy-3,5-bis[[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Human Disease Model